Article
The future promise of advanced therapies in ophthalmology
Six years after the first approved gene therapy in ophthalmology, the field is seeing a flurry of activity in innovative cell and gene therapy (CGT) studies addressing high unmet needs. Here’s what could be in store for the future.
Louis Cicchini
Director, Scientific Affairs, Cell & Gene Therapy at Cencora
Fill out the form below to read more
Pardot Form
Connect with our cell and gene experts
Our tailored solutions address the unique challenges of advanced therapies, from early discovery through to patient delivery, ensuring that innovative treatments reach those who need them most. Connect with our expert team today to learn how Cencora can support your product’s journey.
